Bioextrax AB (85X0) Stock Statistics & Valuation Metrics

Bioextrax AB has a market cap or net worth of €13.05M. The enterprise value is €118.07M.

Bioextrax AB has 46,306,927 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bioextrax AB’s return on equity (ROE) is -0.83 and return on invested capital (ROIC) is -86.58%.

The current PE Ratio of Bioextrax AB is ―. Bioextrax AB’s PEG ratio is 0.47.

In the last 12 months, Bioextrax AB had revenue of 757.00K and earned -17.70M in profits. Earnings per share was -0.45.

In the last 12 months, operating cash flow was -9.83M and capital expenditures -367.00K, giving a free cash flow of -10.19M billion.

Bioextrax AB pays an annual dividend of ―, resulting in a dividend yield of ―

Bioextrax AB upcoming earnings date is May 14, 2026, TBA (Confirmed).

Bioextrax AB as a current ratio of 1.58, with Debt / Equity ratio of 0.00%

In the past 12 months, Bioextrax AB has paid 0.00 in taxes.

Bioextrax AB EV to EBITDA ratio is -6.21, with an EV/FCF ratio of -4.08.

Bioextrax AB has €7.92M in cash and marketable securities with €0.00 in debt, giving a net cash position of €7.92M billion.

Gross margin is -1299.08%, with operating margin of -2426.42%, and net profit margin of -2338.84%.

The average price target for Bioextrax AB is ―, which is 11.43% higher than the current price. The consensus rating is ―